Next Generation Modalities in Drug Discovery & Development

Participants will delve into the science and technology behind novel therapeutic approaches such as gene therapy, RNA-based therapies, cell-based treatments, and biologics including monoclonal antibodies and biosimilars. The course will cover the principles of designing, developing, and evaluating these innovative therapies, emphasizing the regulatory and clinical challenges associated with their development. Through a combination of theoretical lectures, case studies, and interactive discussions, students will gain a comprehensive understanding of how these new modalities are integrated into the drug development pipeline, from initial discovery to market approval. This course is ideal for professionals in pharmaceutical and biotech industries, researchers, and regulatory affairs specialists looking to stay at the forefront of therapeutic innovation.